论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhu H, Zhou B, Chan L, Du Y, Chen T
Received 8 April 2017
Accepted for publication 7 June 2017
Published 13 July 2017 Volume 2017:12 Pages 5023—5038
DOI https://doi.org/10.2147/IJN.S139207
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Thiruganesh Ramasamy
Peer reviewer comments 2
Editor who approved publication: Dr Linlin Sun
Abstract: Rational design and construction of delivery nanosystems for anticancer
metal complexes is a crucial strategy to improve solubility under physiological
conditions and permeability and retention behavior in tumor cells. Therefore,
in this study, we designed and synthesize a transferrin (Tf)-conjugated
nanographene oxide (NGO) nanosystem as a cancer-targeted nanocarrier of Pt
complexes (Tf-NGO@Pt). This nanodelivery system exhibited good solubility under
physiological conditions. Moreover, Tf-NGO@Pt showed higher anticancer efficacy
against MCF human breast cancer cells than the free Pt complex, and effectively
inhibited cancer-cell migration and invasion, with involvement of reactive
oxygen species overproduction. In addition, nanolization also enhanced the
penetration ability and inhibitory effect of the Pt complex toward MCF7 breast
cancer-cell tumor spheroids. The enhancement of anticancer efficacy was
positively correlated with increased cellular uptake and cellular drug
retention. This study provides a new strategy to facilitate the future
application of metal complexes in cancer therapy.
Keywords: cancer
targeting, nanographene oxide, nanomedicine, transferrin, platinum complex,
cell apoptosis